Login / Signup

NKX2.2 immunohistochemistry in the distinction of Ewing sarcoma from cytomorphologic mimics: Diagnostic utility and pitfalls.

Eleanor Russell-GoldmanJason L HornickXiaohua QianVickie Y Jo
Published in: Cancer cytopathology (2018)
NKX2.2 is a highly sensitive but only moderately specific marker for ES. Neuroendocrine neoplasms exhibit variable NKX2.2 expression and remain a significant potential diagnostic pitfall. Thus, NKX2.2 expression should be interpreted in the context of an appropriate immunohistochemical panel (and often with confirmatory molecular testing) for the accurate diagnosis of ES.
Keyphrases
  • poor prognosis
  • binding protein
  • long non coding rna
  • risk assessment
  • mass spectrometry
  • human health
  • simultaneous determination